The national neonatal screening programme for congenital toxoplasmosis in Denmark: Results from the initial four years, 1999-2002

Archives of Disease in Childhood

Volumn 91, Issue 8, 2006, Pages 661-665

  Schmidt, D R ^a   Hogh, B ^b   Andersen, O ^c   Fuchs, J ^c   Fledelius, H ^b   Petersen, E ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; IMMUNOGLOBULIN M; PREDNISONE; PYRIMETHAMINE; SULFADIAZINE;

ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; BRAIN CALCIFICATION; BRAIN DAMAGE; CHORIORETINOPATHY; CLINICAL TRIAL; CONGENITAL TOXOPLASMOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; HYDROCEPHALUS; NEWBORN SCREENING; OUTCOME ASSESSMENT; PHENYLKETONURIA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; TOXOPLASMA GONDII; ULTRASOUND;

ALGORITHMS; ANIMALS; ANTIBODIES, PROTOZOAN; DENMARK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; SENSITIVITY AND SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 33746924402     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2004.066514     Document Type: Article

References (26)

1. Dunn D, Wallon M, Peyron F, et al. Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999;353:1829-33.
2. Guerina NG, Hsu HW, Meissner H, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994;330:1858-63.
3. Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-7.
4. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H. Results of a 20-year follow-up of congenital toxoplasmosis. Lancet 1986;i:254-6.
5. Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000;321:142-7.
6. Ambroise-Thomas P, Petersen E, eds. Congenital toxoplasmosis: scientific background, clinical management and control. France: Springer-Verlag, 2000.
7. Foulon W, Naessens A, Ho-Yen D. Prevention of congenital toxoplasmosis. J Perinat Med 2000;28:337-45.
8. Gilbert R, Dunn D, Wallon M, et al. Ecological comparison of the risk of mother to child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment period. Epidemiol Infect 2001;127:113-20.
9. Gilbert R, Gras L, and the European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. Br J Obstet Gyneaecol 2003;110:112-20.
10. Villena I, Aubert D, Leroux B, et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis 1998;30:295-300.
11. Gras L, Wallon M, Pollak A, et al. European Multicenter Study on Congenital Toxoplasmosis. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 2005;94:1721-31.
12. Romand S, Wallon M, Franck J, et al. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 2001;97:296-300.
13. Sørensen T, Spenter J, Jaliashvili I, et al. An automated time-resolved immunofluometric assay for detection of Toxoplasma gondii specific IgM and IgA antibodies in filterpaper samples from newborns. Clin Chem 2002;48:1981-6.
14. WHO. Report of the WHO Consultation on Public Health Aspects of Toxoplasmosis, Hannover, Federal Republic of Germany 6-8 October 1987. WHO/CDS/VPH/88.74. Geneva: WHO, 1988.
15. Bosch-Driessen EH, Rothova A. Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis. Br J Ophthalmol 1998;82:858-60.
16. Foulon W, Naessens A, Volckaert M, et al. Congenital toxoplasmosis: a prospective survey in Brussels. Br J Obstet Gynaecol 1984;91:419-23.
17. Foulon M, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at 1 year. Am J Obstet Gynecol 1999;180:410-15.
18. Pratlong F, Boulot P, Issert E, et al. Fetal diagnosis of toxoplasmosis in 190 women infected during pregnancy. Prenat Diag 1994;14:191-8.
19. Wallon M, Liou C, Garner P, et al. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 1999;318:1511-14.
20. Wallon M, Kodjikian L, Binquet C, et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 2004;113:1567-72.
21. Brenner DJ, Elliston C. D, Hall EJ, et al. Estimated risks of radiation induced fatal cancer from pediatric CT. AJR 2001;176:289-96.
22. Forsgren M, Gille E, Ljungstrom I, et al. Toxoplasma antibodies in pregnant women in Sweden in 1969, 1979 and 1987. Lancet 1991;337:1413-14.
23. Evengård B, Peterson K, Engman ML, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001;127:121-7.
24. Kortbeek LM, Melker de HE, Veldhuijzen IK, et al. Population-based Toxoplasma seroprevalence study in the Netherlands. Epidemiol Infect 2004;132:839-45.
25. Desmonts G, Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Engl J Med 1974;290:1110-16.
26. Neto EC, Rubin R, Schulte J, et al. Newborn screening for congenital infectious diseases. Emerg Infect Dis 2004;10:1069-73.